Results
|
|
101.
|
A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study. [electronic resource] by
- Matulonis, Ursula A
- Sill, Michael W
- Makker, Vicky
- Mutch, David G
- Carlson, Jay W
- Darus, Christopher J
- Mannel, Robert S
- Bender, David P
- Crane, Erin K
- Aghajanian, Carol
Producer: 20190417
In:
Gynecologic oncology vol. 152
Availability: No items available.
|
|
|
102.
|
A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial. [electronic resource] by
- Berkenblit, Anna
- Matulonis, Ursula A
- Kroener, Joan F
- Dezube, Bruce J
- Lam, Gil N
- Cuasay, Luceli C
- Brünner, Nils
- Jones, Terence R
- Silverman, Michael H
- Gold, Michael A
Producer: 20051104
In:
Gynecologic oncology vol. 99
Availability: No items available.
|
|
|
103.
|
Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine. [electronic resource] by
- Martin, Lainie P
- Konner, Jason A
- Moore, Kathleen N
- Seward, Shelly M
- Matulonis, Ursula A
- Perez, Raymond P
- Su, Ying
- Berkenblit, Anna
- Ruiz-Soto, Rodrigo
- Birrer, Michael J
Producer: 20171108
In:
Gynecologic oncology vol. 147
Availability: No items available.
|
|
|
104.
|
Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival. [electronic resource] by
- Clauss, Adam
- Ng, Vivian
- Liu, Joyce
- Piao, Huiying
- Russo, Moises
- Vena, Natalie
- Sheng, Qing
- Hirsch, Michelle S
- Bonome, Tomas
- Matulonis, Ursula
- Ligon, Azra H
- Birrer, Michael J
- Drapkin, Ronny
Producer: 20100423
In:
Neoplasia (New York, N.Y.) vol. 12
Availability: No items available.
|
|
|
105.
|
Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer. [electronic resource] by
- Campos, Susana M
- Berlin, Suzanne T
- Parker, Leroy M
- Chen, Wendy Y
- Bunnell, Craig A
- Atkinson, Tina
- Lee, Julie
- Matulonis, Ursula
- Hirsch, Michelle S
- Harris, Lyndsay
- Krasner, Carolyn N
Producer: 20101123
In:
International journal of clinical oncology vol. 15
Availability: No items available.
|
|
|
106.
|
Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy. [electronic resource] by
- Rodriguez, Noah
- Rauh-Hain, J Alejandro
- Shoni, Melina
- Berkowitz, Ross S
- Muto, Michael G
- Feltmate, Colleen
- Schorge, John O
- Del Carmen, Marcela G
- Matulonis, Ursula A
- Horowitz, Neil S
Producer: 20120606
In:
Gynecologic oncology vol. 125
Availability: No items available.
|
|
|
107.
|
Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma. [electronic resource] by
- Matulonis, Ursula A
- Sharma, Sudarshan
- Ghamande, Sharad
- Gordon, Michael S
- Del Prete, Salvatore A
- Ray-Coquard, Isabelle
- Kutarska, Elzbieta
- Liu, Hua
- Fingert, Howard
- Zhou, Xiaofei
- Danaee, Hadi
- Schilder, Russell J
Producer: 20130206
In:
Gynecologic oncology vol. 127
Availability: No items available.
|
|
|
108.
|
Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer. [electronic resource] by
- Pham, Elizabeth
- Birrer, Michael J
- Eliasof, Scott
- Garmey, Edward G
- Lazarus, Douglas
- Lee, Christina R
- Man, Shan
- Matulonis, Ursula A
- Peters, Christian G
- Xu, Ping
- Krasner, Carolyn
- Kerbel, Robert S
Producer: 20151209
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 21
Availability: No items available.
|
|
|
109.
|
A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer. [electronic resource] by
- Liu, Joyce F
- Tolaney, Sara M
- Birrer, Michael
- Fleming, Gini F
- Buss, Mary K
- Dahlberg, Suzanne E
- Lee, Hang
- Whalen, Christin
- Tyburski, Karin
- Winer, Eric
- Ivy, Percy
- Matulonis, Ursula A
Producer: 20131113
In:
European journal of cancer (Oxford, England : 1990) vol. 49
Availability: No items available.
|
|
|
110.
|
Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations. [electronic resource] by
- Birkbak, Nicolai Juul
- Kochupurakkal, Bose
- Izarzugaza, Jose M G
- Eklund, Aron C
- Li, Yang
- Liu, Joyce
- Szallasi, Zoltan
- Matulonis, Ursula A
- Richardson, Andrea L
- Iglehart, J Dirk
- Wang, Zhigang C
Producer: 20140725
In:
PloS one vol. 8
Availability: No items available.
|
|
|
111.
|
BRAF and AXL oncogenes drive RIPK3 expression loss in cancer. [electronic resource] by
- Najafov, Ayaz
- Zervantonakis, Ioannis K
- Mookhtiar, Adnan K
- Greninger, Patricia
- March, Ryan J
- Egan, Regina K
- Luu, Hoang Son
- Stover, Daniel G
- Matulonis, Ursula A
- Benes, Cyril H
- Yuan, Junying
Producer: 20190531
In:
PLoS biology vol. 16
Availability: No items available.
|
|
|
112.
|
Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer. [electronic resource] by
- Matulonis, Ursula A
- Horowitz, Neil S
- Campos, Susana M
- Lee, Hang
- Lee, Julie
- Krasner, Carolyn N
- Berlin, Suzanne
- Roche, Maria R
- Duska, Linda R
- Pereira, Lauren
- Kendall, Deborah
- Penson, Richard T
Producer: 20090106
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 26
Availability: No items available.
|
|
|
113.
|
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. [electronic resource] by
- Ledermann, Jonathan
- Harter, Philipp
- Gourley, Charlie
- Friedlander, Michael
- Vergote, Ignace
- Rustin, Gordon
- Scott, Clare
- Meier, Werner
- Shapira-Frommer, Ronnie
- Safra, Tamar
- Matei, Daniela
- Macpherson, Euan
- Watkins, Claire
- Carmichael, James
- Matulonis, Ursula
Producer: 20120419
In:
The New England journal of medicine vol. 366
Availability: No items available.
|
|
|
114.
|
Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal carcinoma (NCT 01283035). [electronic resource] by
- Lee, Elizabeth K
- Tan-Wasielewski, Zhenying
- Aghajanian, Carol
- Coleman, Robert L
- Curtis, Jennifer
- Hirsch, Michelle S
- Matulonis, Ursula A
- Cantley, Lewis C
- Mills, Gordon B
- Doyle, L Austin
- Liu, Joyce F
Publication details: Gynecologic oncology reports May 2020
In:
Gynecologic oncology reports vol. 32
Availability: No items available.
|
|
|
115.
|
Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancer. [electronic resource] by
- Veneris, Jennifer Taylor
- Lee, Elizabeth K
- Goebel, Emily A
- Nucci, Marisa R
- Lindeman, Neal
- Horowitz, Neil S
- Lee, Larissa
- Raut, Chandrajit P
- Crotzer, David
- Matulonis, Ursula
- Konstantinopoulos, Panagiotis A
- Campos, Susana
Producer: 20190812
In:
Gynecologic oncology vol. 153
Availability: No items available.
|
|
|
116.
|
The Feasibility and Effects of Acupuncture on Quality of Life Scores During Chemotherapy in Ovarian Cancer: Results from a Pilot, Randomized Sham-Controlled Trial. [electronic resource] by
- Lu, Weidong
- Matulonis, Ursula A
- Dunn, Julie E
- Lee, Hang
- Doherty-Gilman, Anne
- Dean-Clower, Elizabeth
- Goodman, Annekathryn
- Davis, Roger B
- Buring, Julie
- Wayne, Peter
- Rosenthal, David S
- Penson, Richard T
Publication details: Medical acupuncture 12 2012
In:
Medical acupuncture vol. 24
Availability: No items available.
|
|
|
117.
|
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response. [electronic resource] by
- Zervantonakis, Ioannis K
- Iavarone, Claudia
- Chen, Hsing-Yu
- Selfors, Laura M
- Palakurthi, Sangeetha
- Liu, Joyce F
- Drapkin, Ronny
- Matulonis, Ursula
- Leverson, Joel D
- Sampath, Deepak
- Mills, Gordon B
- Brugge, Joan S
Producer: 20180116
In:
Nature communications vol. 8
Availability: No items available.
|
|
|
118.
|
Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer. [electronic resource] by
- Callahan, Michael J
- Nagymanyoki, Zoltan
- Bonome, Tomas
- Johnson, Michael E
- Litkouhi, Babak
- Sullivan, Elizabeth H
- Hirsch, Michelle S
- Matulonis, Ursula A
- Liu, Joyce
- Birrer, Michael J
- Berkowitz, Ross S
- Mok, Samuel C
Producer: 20090205
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 14
Availability: No items available.
|
|
|
119.
|
Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine. [electronic resource] by
- Matulonis, Ursula A
- Birrer, Michael J
- O'Malley, David M
- Moore, Kathleen N
- Konner, Jason
- Gilbert, Lucy
- Martin, Lainie P
- Bauer, Todd M
- Oza, Amit M
- Malek, Karim
- Pinkas, Jan
- Kim, Stella K
Producer: 20200527
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25
Availability: No items available.
|
|
|
120.
|
Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors. [electronic resource] by
- Campos, Susanna M
- Matulonis, Ursula A
- Penson, Richard T
- Lee, Hang
- Berkowitz, Ross S
- Duska, Linda R
- Fuller, Arlan F
- Wilson, Kara S
- Puchalski, Thomas A
- Supko, Jeffrey G
- Seiden, Michael V
Producer: 20031020
In:
Gynecologic oncology vol. 90
Availability: No items available.
|